Literature DB >> 9052394

High-dose chemotherapy of metastatic breast cancer: the end of the beginning?

J Crown.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9052394      PMCID： PMC2063305          DOI： 10.1038/bjc.1997.81

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  33 in total

1.  Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells.

Authors:  J Crown; C Wassherheit; T Hakes; D Fennelly; L Reich; M Moore; J Schneider; J Curtin; S C Rubin; B Reichman
Journal:  J Natl Cancer Inst       Date:  1992-12-16       Impact factor: 13.506

2.  Use of very-high-dose chemotherapy with autologous bone marrow transplantation in treatment of breast cancer.

Authors:  F R Dunphy; G Spitzer
Journal:  J Natl Cancer Inst       Date:  1992-01-15       Impact factor: 13.506

3.  A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

Authors:  K Antman; L Ayash; A Elias; C Wheeler; M Hunt; J P Eder; B A Teicher; J Critchlow; J Bibbo; L E Schnipper
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

4.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

5.  Complete responders to chemotherapy in metastatic breast cancer. Characterization and analysis.

Authors:  D A Decker; D L Ahmann; H F Bisel; J H Edmonson; R G Hahn; J R O'Fallon
Journal:  JAMA       Date:  1979-11-09       Impact factor: 56.272

6.  Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer.

Authors:  J Crown; A Kritz; L Vahdat; L Reich; M Moore; N Hamilton; J Schneider; M Harrison; T Gilewski; C Hudis
Journal:  J Clin Oncol       Date:  1993-06       Impact factor: 44.544

7.  Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy.

Authors:  W P Peters; G Rosner; M Ross; J Vredenburgh; B Meisenberg; C Gilbert; J Kurtzberg
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

8.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

Authors:  J H Goldie; A J Coldman
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

9.  High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer.

Authors:  M J Kennedy; R A Beveridge; S D Rowley; G B Gordon; M D Abeloff; N E Davidson
Journal:  J Natl Cancer Inst       Date:  1991-07-03       Impact factor: 13.506

10.  High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.

Authors:  W P Peters; M Ross; J J Vredenburgh; B Meisenberg; L B Marks; E Winer; J Kurtzberg; R C Bast; R Jones; E Shpall
Journal:  J Clin Oncol       Date:  1993-06       Impact factor: 44.544
View more
  1 in total

1.  The growth law of primary breast cancer as inferred from mammography screening trials data.

Authors:  D Hart; E Shochat; Z Agur
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.